Skip to content

Lung Cancer Blog

Everything about lung cancer is here.

Menu
  • Home
  • About Us
  • Lung Cancer
    • Lung Cancer News
    • Causes of Lung Cancer
    • Lung Cancer Symptoms
    • Types of Lung Cancer
    • Stages of Lung Cancer
    • Lung Cancer Treatment
    • Lung Cancer Drugs
    • Lung Cancer In Ayurveda
    • Chinese Herbs For Lung Cancer
  • Researches
  • Studies
  • Stories
  • Sitemap
  • Contact Us
Menu
lung | Lung Cancer

Study: Tagrisso As Backbone Therapy for Lung Cancer

Posted on March 31, 2025
Post Views: 306

lung | Lung CancerLung cancer remains the leading cause of cancer-related deaths worldwide. It is broadly classified into small cell lung cancer and non-small cell lung cancer. The latter accounts for about 80% of the cases. According to the new study results presented at the European Lung Cancer Congress 2025, Tagrisso has reinforced as the backbone therapy for EGFR-mutated lung cancer. The data showed that adding savolitinib or datapotamab deruxtecandlnk at the time of lung cancer progression can help prolong responses to the treatment.

The study demonstrated the role of Tagrisso as monotherapy as well as the backbone for novel combinations across stages and settings of epidermal growth factor receptor-mutated NSCLC. The highlights of the study are discussed here.

LAURA Phase III trial of Tagrisso in unresectable, Stage III EGFRm NSCLC after chemo radiotherapy. ORCHARD Phase II platform trial of Tagrisso and Datroway in advanced EGFRm NSCLC. FLAURA2 Phase III Trial of Tagrisso plus chemotherapy as first-line treatment for advanced EGFRm NSCLC. SAVANNAH Phase II trial of Tagrisso and Orpathys in advanced EGFRm NSCLC with high levels of MET overexpression following disease progression on first-line Tagrisso. Tagrisso has demonstrated encouraging survival trend in Stage III setting in LAURA trial. The updated results have shown an improved trend towards benefits with Tagrisso in comparison to placebo in patients with Stage III NSCLC. The trial will continue to access overall survival benefit with Tagrisso as a key endpoint athlete the final analysis. Previously, Tagrisso has demonstrated a significant and highly clinical meaningful improvement in progression-free survival.

Tagrisso has been used to treat lung cancer patients worldwide and AstraZeneca continues to explore Tagrisso as a treatment for patients across multiple stages of EGFRm NSCLC. Tagrisso is also being investigated in the early-stage adjuvant resectable setting in ADAURA2 Phase III trial.

The information shared in this blog is for educational purposes only.

Subscribe to our newsletter or follow us on Facebook or Twitter today to stay informed and never miss an update!

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on Threads (Opens in new window) Threads
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on Tumblr (Opens in new window) Tumblr
  • Click to share on Pocket (Opens in new window) Pocket
  • Click to share on Telegram (Opens in new window) Telegram

Like this:

Like Loading...

Subscribe Us

Popular Articles

  • Lung Cancer Treatment in Ayurveda (7,322)
  • Lung Cancer: Symptoms and Treatment (5,651)
  • What is Non-Small-Cell Lung Cancer? (5,551)

Recent Comments

  • Lung Cancer on New Study To Help Advance Research In Lung Cancer
  • Laurie B Grimes on New Study To Help Advance Research In Lung Cancer
  • Lung Cancer on Asbestos and Lung Cancer – What’s The Link?

Recent Articles

  • Predicting Lung Cancer Risk with AI based Deep Learning Model May 26, 2025
  • FDA Grants Accelerated Approval to Telisotuzumab Vedotin-tllv for NSCLC May 19, 2025
  • Heart-Sparing Technique in Lung Cancer Radiotherapy May 12, 2025
  • Origins of Common Lung Cancer Linked to Smoking Discovered May 5, 2025
  • Lung Cancer Screening Is Beneficial For Non-Smokers As Well April 28, 2025

Lung Cancer Blog

Lung Cancer Blog provides all lung cancer related information for educational purposes.

Disclaimer

Some post may contain affiliate links, purchasing that product not going to cost extra but by your purchase Lung Cancer will get some little commission and that amount will help in surviving this website. So, please don’t hesitate to buy from these affiliate links.

Contact Us

If you have any query or suggestions about our blog, please feel free to email us at  lungcancersymptomsx@gmail.com.

Copyright © 2012 - 2025 Lung Cancer Blog. Wordpress by Vipasha.
  • Privacy Policy
  • About Us
  • Sitemap
  • Contact Us
%d